The information contained in the Organizational Database (ODB) is provided for informational purposes only. There is no implied endorsement by NORD. NORD does not promote or endorse participation in any specific organization. The information is subject to change without notice. Every effort is made to ensure that the details for each entry are as current as possible.
555 Price Avenue
Redwood City, CA 94063
The Vascular Cures was formed in 1998 to improve public recognition of the prevalence and seriousness of vascular disease, with an initial focus on increasing public awareness to improve prevention, diagnosis, and comprehensive treatment of peripheral arterial disease (PAD). The foundation disseminates educational information to the public, fosters vascular disease patient advocacy initiatives, and provides information to patients and to those at risk for development of common vascular disorders. PAD occurs because of blockages in the arteries in the legs, but it may also indicate that blockages are occurring in the arteries to the heart or brain. The Vascular Disease Foundation is increasing awareness and understanding of PAD and other vascular diseases for which early diagnosis and treatment may be very important.
The National Organization for Rare Disorders (NORD) web site, its databases, and the contents thereof are copyrighted by NORD. No part of the NORD web site, databases, or the contents may be copied in any way, including but not limited to the following: electronically downloading, storing in a retrieval system, or redistributing for any commercial purposes without the express written permission of NORD. Permission is hereby granted to print one hard copy of the information on an individual disease for your personal use, provided that such content is in no way modified, and the credit for the source (NORD) and NORD’s copyright notice are included on the printed copy. Any other electronic reproduction or other printed versions is strictly prohibited.
NORD's Rare Disease Information Database is copyrighted and may not be published without the written consent of NORD.